Sirolimus-Eluting Balloon Strategy Matches Drug-Eluting Stents in Large International PCI Trial
43 Articles
43 Articles
Sirolimus-eluting balloon strategy matches drug-eluting stents in large international PCI trial
New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus-eluting balloons with bailout stenting only if necessary was noninferior to routine drug-eluting stent (DES) implantation as part of the treatment for de novo coronary artery disease.
Selution's 1-Year Data Push Drug-Coated Balloons Further Into the Mainstream
(MedPage Today) -- SAN FRANCISCO -- The investigational Selution drug-coated balloon (DCB or DEB) edged closer to primetime in percutaneous coronary intervention (PCI), following the release of two noninferiority trials here at the Transcatheter...
Cordis Unveiled Breakthrough Results from SELUTION DeNovo and SELUTION4ISR Randomized Trials at TCT 2025, Transforming Coronary Artery Disease (CAD) Treatment Beyond Stenting
SELUTION DeNovo Trial - the largest randomized Drug Eluting Balloon trial - demonstrates a SELUTION SLR™ DEB strategy is non-inferior to a Drug Eluting Stent treatment strategy in de novo lesions.SELUTION4ISR, a randomized controlled trial, proves SELUTION SLR™ DEB is…
New Drug-Eluting Balloon May Be as Safe and Effective as Conventional Metal Stents for Repeat Percutaneous Coronary Interventions
Trial led by Mount Sinai researcher could lead to safer and easier treatment for patients with coronary in-stent restenosis
TCT 2025: Selution SLR meets non-inferiority in de novo and in-stent restenosis trials
Christian Spaulding presents SELUTION DeNovo trial results at TCT 2025 Cordis has announced results from the SELUTION DeNovo and SELUTION4ISR trials, presented during a late-breaking trials session at the 2025 Transcatheter Cardiovascular Therapeutics (TCT) meeting (25–28 October, San Francisco, USA). Both randomised clinical trials demonstrated positive outcomes that met primary endpoints for the Selution SLR drug-eluting balloon (DEB) compared…
Coverage Details
Bias Distribution
- 78% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
















